MEDTRONIC RENAL DENERVATION ANNOUNCEMENTS

May 18, 2021
Late Breaking Data at EuroPCR Demonstrates Long-Term Benefts of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive patients

June 25, 2020
New Real-World Data from Medtronic Global SYMPLICITY Registry Show Renal Denervation Lowered Blood Pressure in Patients with Hypertension Out to Three Years

March 29, 2020
SPYRAL-HTN OFF MED: Renal Denervation Potential Option For Patients with Untreated Hypertension

February 4, 2020
Medtronic Begins New Pilot Study as Part of SPYRAL HTN Clinical Program for Renal Denervation in Hypertension Patients

May 22, 2019
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients

November 8, 2018
Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication

April 9, 2018
Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

May 23, 2018
New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication

August 28, 2017
Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions

PARTNERSHIPS FOR RDN AND HYPERTENSION

Medtronic provides sponsorship, congress support, and education for partners around the world who belong to the broader hypertension community. Partners include: